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Radiationa b s t r a c t
This study focuses on clarifying the contribution of sulfation to radiation-induced apoptosis in
human Burkitt’s lymphoma cell lines, using 30-phosphoadenosine 50-phosphosulfate transporters
(PAPSTs). Overexpression of PAPST1 or PAPST2 reduced radiation-induced apoptosis in Namalwa
cells, whereas the repression of PAPST1 expression enhanced apoptosis. Inhibition of PAPST slightly
decreased keratan sulfate (KS) expression, so that depletion of KS signiﬁcantly increased radiation-
induced apoptosis. In addition, the repression of all three N-acetylglucosamine-6-O-sulfotransferas-
es (CHST2, CHST6, and CHST7) increased apoptosis. In contrast, PAPST1 expression promoted the
phosphorylation of p38 MAPK and Akt in irradiated Namalwa cells. These ﬁndings suggest that 6-
O-sulfation of GlcNAc residues in KS reduces radiation-induced apoptosis of human Burkitt’s lym-
phoma cells.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Sulfation of a variety of molecules, including glycoproteins,
proteoglycans (PGs), and glycolipids, is an important posttransla-
tional modiﬁcation, which modiﬁes the properties of molecules
by conferring a negative charge. Heparan sulfate (HS) and chon-
droitin sulfate (CS) have highly-sulfated glycosaminoglycan
(GAG) chains, which play important roles in many biological pro-
cesses. For example, a number of ﬁbroblast growth factors (FGFs)
interact with these sulfated GAG subtypes [1], so that inhibition
of sulfation was able to reduce the signaling of FGF. Therefore,
the sulfation of PGs may regulate numerous physiological and
pathological events.The process of sulfation requires the involvement of a high en-
ergy form of the universal sulfate donor, namely, 30-phosphoade-
nosine 50-phosphosulfate (PAPS). In higher organisms, PAPS is
synthesized in the cytosol or nucleus by PAPS synthetases [2],
and PAPS transporters (PAPSTs) transfer PAPS from the cytosol into
the Golgi lumen for the sulfation of sugar residues. Recently, two
members of the PAPSTs, PAPST1 (SLC35B2) and PAPAT2 (SLC35B3),
were identiﬁed in humans [3,4] and it was suggested that PAPSTs
regulate the sulfation process in addition to sulfotransferases [5].
It has been reported that some sulfated structures alter the
expression of molecules associated with the progression of cancer.
In colon adenocarcinoma, the amount of sulfated glycoproteins
decreased in the order normal mucosa, primary tumors, and met-
astatic tumors [6], and down-regulation of galactose-3-O-sulfo-
transferase-2 reduced the expression of sulfomucins in colon
adenocarcinomas [7]. Instead, an increase in sialylation was associ-
ated with malignant transformation of colonic epithelial cells. The
change of mucin production from sulfated to sialylated is a signif-
icant phenotypic alteration during tumor progression.
This study investigated the contribution of sulfation of PGs to
radiation-induced apoptosis using PAPSTs and identiﬁed that the
sulfation of keratan sulfate proteoglycan (KSPG) caused radioresis-
tance in human Burkitt’s lymphoma cell lines.
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2.1. Cell culture and reagents
Human Burkitt’s lymphoma cell lines Raji and Daudi were ob-
tained from RIKEN Bio Resource Center and Namalwa was obtained
from ATCC, and they were maintained in a medium consisting of
RPMI 1640 medium (Gibco, Grand Island, NY, USA) supplemented
with 10% heat-inactivated fetal calf serum (FCS). Anti-HS (HepSS-1,
10E4), anti-CS-A (2H6), anti-CS-D (MO-225), and anti-keratan sul-
fate (KS) (5-D-4, BCD-4) monoclonal antibodies were purchased
from Siekagaku Kogyo (Tokyo, Japan).
2.2. Transfection of PAPST genes
Namalwa cells were transfected with pAMo vectors [8] contain-
ing human PAPST1 or PAPST2 genes by electroporation using a
GenePulser apparatus (Bio-Rad, Richmond, CA, USA) (Namalwa-
PAPST1, or Namalwa-PAPST2). The transfectants were selected by
the addition of 0.6 mg/ml geneticin (G418) (Gibco) to the medium.
2.3. In vitro siRNA assay
Stealth RNAi is a type of chemically modiﬁed siRNA obtained
from Invitrogen (Carlsbad, CA, USA). The synthesized oligonucleo-
tides for the target site of each gene were as follows: PAPST1, 50-
ugg acc cag cua ugg uuc uuc cga u-30 and 50-auc gga aga acc aua
gcu ggg ucc a-30; the negative control for PAPST1, 50-ugg acc ucg
gua uug uuc cca cga u-30 and 50-auc gug gga aca aua ccg agg ucc
a-30; PAPST2, aac acu ucc uug ggc uac cug aau u-30 and 50-aau
uca ggu agc cca agg aag ugu u-30; the negative control for PAPST2,
50-aac uuc cuu ggc gau ccg uac aau u-30 and 50-aau ugu acg gau cgc
caa gga agu u-30; CHST-2, 50-ccu cuc gga aug aag gug uuc cgu a-30
and 50-uac gga aca ccu uca uuc cga gag g-30; CHST-6, 50-aua ggc auc
aaa cac guc cau guc g-30 and 50-cga cau gga cgu guu uga ugc cua u-
30; and CHST-7, 50-uaa aga guu cgc cca gga agg acg a-30 and 50-ucg
ucc uuc cug ggc gaa cuc uuu a-30. Each stealth RNAi duplex was
transfected at a ﬁnal concentration of 50 nM using Lipofectamine™
RNAiMAX in accordance with the manufacturer0s protocol
(Invitrogen).
2.4. Quantitative RT-PCR assay
A quantitative RT-PCR assay was performed to determine the
amount of each transcript in Namalwa cells using a 7500 Fast
Real-Time PCR System (Applied Biosystems, Foster City, CA, USA).
The absolute amount of each transcript (copies/ll) was divided
by that of b-actin (copies/ll) for normalization. Each normalized
amount was further divided by that of the control sample to obtain
the relative rate of expression.
2.5. Antibody array
The protein expression proﬁle of Namalwa cells was deter-
mined using a Human Phospho-MAPK Array Kit in accordance with
the manufacturer’s protocol (R&D Systems, Minneapolis, MN, USA).
Brieﬂy, Namalwa-pAMo cells transfected with stealth RNAi target-
ing the PAPST1 gene and Namalwa-PAPST1 cells transfected with
the negative control stealth RNAi were irradiated with 20 Gy of
X-rays 48 h after transfection. The cell lysates were prepared 6 h
after irradiation and each array was incubated with 200–300 lg
of lysate protein. The signals were generated using ECL Plus Wes-
tern Blot Detection Reagents (GE Healthcare, Little Chalfont, UK)
and detected using a luminescent image analyzer LAS-4000 mini
(Fujiﬁlm, Tokyo, Japan). The detected signals were quantiﬁed usingMulti Gause ver 3.0 image analysis software (Fujiﬁlm). Each value
was calculated as a relative value compared with that in the posi-
tive control.
2.6. Western blot analysis
Phosphorylation of p38 and Akt was also examined by western
blot analysis. A 50 lg sample of each lysate of transfectants was
electrophoresed on an any KD Mini-PROTEAN TGX gel (BioRad)
and transferred to an Immobilon PVDF membrane. Anti-phospho-
p38 MAPK (Thr180/Tyr182) (9211) and anti-p38 MAPK (9212)
antibodies (Cell Signaling Technology, Danvers, MA, USA) were
used as probes at 1:500 dilution. An anti-b-Actin antibody (4967)
was used as loading control at 1:1000 dilution (Cell Signaling
Technology).
2.7. Apoptosis detection
Radiation-induced apoptosis was assessed by microscopic
examination of nuclear morphology using Hoechst 33258 (Calbio-
chem, La Jolla, CA, USA), as described previously [9]. Brieﬂy, cells
were plated at a density of 3  105 cells per 3.5-cm dish and irra-
diated with X-rays. The condensed chromatin of nuclei was visual-
ized by staining with 0.1 mg/ml of Hoechst 33258 after ﬁxation
with glutaraldehyde. The percentage of apoptotic cells was deter-
mined from the examination of 2,000 cells in 10 ﬁelds.
2.8. Irradiation
The cells were irradiated with X-rays using an X-ray generator
Pantak HF-320S (Shimazu, Kyoto, Japan) at a dose rate of approxi-
mately 2.4 Gy/min.
3. Results
3.1. The overexpression of PAPST in Namalwa cells decreases
radiation-induced apoptosis
We evaluated the transcript levels of PAPST1 and PAPST2 in a
human B-lymphoma cell line, Namalwa cells (Fig. 1A). The level
of PAPST1 transcripts was approximately 5-fold higher than that
of PAPST2. Namalwa cells were transfected with an expression vec-
tor containing the coding sequence of human PAPST1 or PAPST2.
The level of PAPST1 transcripts in Namalwa-PAPST1 cells was
2.5-fold higher than that in Namalwa-pAMo or Namalwa-PAPST2
cells. In contrast, the level of PAPST2 transcripts in Namalwa-
PAPST2 cells was approximately 3-fold higher than that in Nam-
alwa-pAMo or Namalwa-PAPST1 cells and reached 80% of the level
of PAPST1 transcripts in Namalwa-pAMo cells.
The level of apoptosis was determined in each transfectant by
Hoechst staining 24 h after irradiation (Fig. 1B). Irradiation in-
creased the apoptosis of Namalwa-pAMo cells in a dose-dependent
manner. In contrast, overexpression of PAPST decreased radiation-
induced apoptosis in Namalwa cells. In particular, the most signif-
icant inhibition of apoptosis was seen at 20 Gy of irradiation, and
the number of apoptotic cells in Namalwa-PAPST1 and -PAPST2
cells was approximately 60% of that in Namalwa-pAMo cells. Over-
expression of PAPST1 and PAPST2 decreased apoptosis by almost
the same extent.
3.2. Repression of PAPST increases radiation-induced apoptosis in
Namalwa cells overexpressing each PAPST
Namalwa-PAPST1 or -PAPST2 cells were transfected with
stealth RNAi targeted against the PAPST1 or PAPST2 gene, respec-
Fig. 1. Inhibition of radiation-induced apoptosis in Namalwa cells overexpressing PAPST. (A) The relative transcript levels of PAPST1 and PAPST2 were determined in each
transfectant by quantitative RT-PCR. (B) The percentage of apoptotic cells was determined by Hoechst 33258 staining 24 h after irradiation at 10, 20, or 30 Gy. (C, D)
Namalwa-PAPST1 or Namalwa-PAPST2 was transiently transfected with stealth RNAi targeting the PAPST1 (PAPST1 siRNA) or PAPST2 (PAPST2 siRNA) genes and cultured in
RPMI 1640 with 10% FCS for 48 h after transfection. The percentage of apoptotic cells was determined using Hoechst 33258 staining 24 h after irradiation. Values represent
mean ± S.D. Similar ﬁndings were observed in three independent experiments. ⁄P < 0.05; ⁄⁄P < 0.01.
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X-rays at 48 h after transfection, and then apoptosis of the cells
was determined by Hoechst staining. Repression of each PAPST in
Namalwa cells overexpressing the corresponding PAPST gene sig-
niﬁcantly increased the population of apoptotic cells at 20 or
30 Gy of irradiation.
3.3. KSPG is expressed in Namalwa cells
The level of cell surface expression of proteoglycans was stud-
ied by ﬂow cytometry using anti-HS, anti-CS (CS-A, CS-D), and
anti-KS antibodies. HS was not expressed on the surface of Nam-
alwa cells and the expression levels of CS-A and CS-D were extre-
mely low, whereas KS was signiﬁcantly detected using the anti-KS
antibody (BCD-4) (Fig. 2A). However, Namalwa cells were not pos-
itively stained with another anti-KS antibody (5-D-4), which was
highly speciﬁc for sulfated poly(N-acetyllactosamine) domains of
KS chains. Inhibition of sulfation using chlorate, an inhibitor of
PAPS sulfurylase, slightly reduced the expression level of the
BCD-4 epitope in Namalwa cells (Fig. 2B). In addition, siRNA-med-
iated PAPST1 repression decreased the level of the BCD-4 epitope,
although the repression of PAPST2 did not reduce it (Fig. 2C). Nam-
alwa cells repressing both PAPSTs reduced the level of BCD-4 epi-
tope to the same extent as cells repressing only PAPST1.
3.4. KSPG decreases radiation-induced apoptosis in Namalwa cells
Namalwa, Daudi, and Raji cells were incubated with keratanase
for eliminative cleavage of KS chains from the cell surface. The le-
vel of KSPG expression was determined in the treated cells by ﬂow
cytometric analysis using the BCD-4 antibody, and it was con-
ﬁrmed that KSPG was completely removed from these cells
(Fig. 3A). In addition, the absence of KS chains on the cell surface
signiﬁcantly enhanced radiation-induced apoptosis in Namalwa
cells at all the doses tested (Fig. 3B). In contrast, heparitinase I or
chondroitinase ABC treatment did not signiﬁcantly increaseradiation-induced apoptosis in Namalwa cells; however, these
treatments tended to enhance it (data not shown). Hence, the
expression levels of HS and CS in Namalwa cells might be too
low to affect apoptosis.
3.5. Sulfation of KSPG plays a signiﬁcant role in the inhibition of
radiation-induced apoptosis in Namalwa cells
The sulfation process enhanced by PAPST1 may be involved in
the inhibition of radiation-induced apoptosis in Burkitt’s lym-
phoma cell lines. Two galactose-6-O-sulfotransferases (Gal6ST)
(CHST1, CHST3) and three N-acetylglucosamine-6-O-sulfotransfe-
rases (GlcNAc6ST) (CHST2, CHST6 and CHST7) were identiﬁed as
enzymes involved in the sulfation of KSPG [10–12] (Fig. 4A). How-
ever, only three sulfotransferases, CHST2, CHST6, and CHST7 were
expressed in Namalwa cells (data not shown). Therefore, each gene
was repressed in Namalwa cells using single siRNA transfection to
determine which sulfation is involved in radiation-induced apop-
tosis. However, there was no signiﬁcant difference in apoptosis
among transfectants after irradiation at 10, 20, or 30 Gy (data not
shown). Moreover, double siRNA transfection did not enhance
radiation-induced apoptosis except for the repression of both
CHST6 and CHST7 (Fig. 4B). In contrast, the triple repression of
CHST2, CHST6, and CHST7 reduced each transcript level by 44%,
68%, and 32%, respectively, (Fig. 4C), and it signiﬁcantly increased
radiation-induced apoptosis (Fig. 4D). These ﬁndings suggest that
sulfation of KS is essential for promoting anti-apoptotic signaling
after irradiation; in particular, the KS-mediated apoptosis depends
on 6-O-sulfation of GlcNAc residues.
3.6. Expression of PAPST1 is involved in the activation of Akt and p38
MAPK in Namalwa cells
The relative levels of phosphorylation of nine mitogen-activated
protein kinases (MAPKs) and nine other serine/threonine kinases
were analyzed using an antibody-based array to understand the
Fig. 2. Involvement of PAPST1 in KSPG synthesis in Namalwa cells. (A) Namalwa cells were stained with each anti-proteoglycan antibody and examined by FACS. (B)
Namalwa cells were cultured in complete medium with 50 mM sodium chlorate for 48 h to inhibit PAPS synthesis. The treated cells were stained with the BCD-4 antibody.
The median position of each peak is shown in the histograms. (C) Namalwa cells were transiently transfected with stealth RNAi targeting the PAPST1 or PAPST2 gene, or both
and cultured for 96 h. These cells were examined by FACS after BCD-4 staining.
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fects (Fig. 5A). Phosphorylation of p38 MAPK in PAPST1-over-
expressing cells increased more than twofold that in PAPST1-
repressed cells after irradiation (Fig. 5B). Phosphorylation of Erk
and Akt increased slightly in PAPST1-overexpressing cells com-
pared with PAPST1-repressed cells. In addition, western blot anal-
ysis showed that phosphorylation of p38 MAPK was induced in
PAPST1-overexpressing cells by irradiation more than in PAPST1-
repressed cells, although these cells showed the same level of
p38 protein expression (Fig. 5C).
The inhibition of PI-3K, MEK, or p38 MAPK in Namalwa cells
was performed using appropriate inhibitors (LY294002, PD98059,
and SB203580, respectively) (Fig. 5D). Inhibition of PI-3K or p38
MAPK in Namalwa cells increased radiation-induced apoptosis,
whereas inhibition of MEK did not increase radiation-induced
apoptosis.4. Discussion
KS is expressed in the cornea, cartilage, bone, brain, and epithe-
lial tissues, but it was not reported whether lymphoma cells ex-
pressed KS on the cell surface. However, it seems that KS
molecules modify a variety of proteins with a range of localization
patterns [13]. In this study, two kinds of anti-KS antibodies (5-D-4
and BCD-4) were used for the analysis of the cell surface expres-
sion of KS. 5-D-4 is highly speciﬁc for sulfated poly(N-acetyllactos-
amine) domains on KS oligosaccharides [14], whereas BCD-4 reacts
with KS bound to a core protein [15]. Burkitt’s lymphoma cell lines
were stained with BCD-4 but not 5-D-4 (Fig. 3A), so they were
likely to express sparsely-sulfated KS. In addition, repression of
PAPST, which reduced sulfation, slightly decreased the expression
of the BCD-4 epitope in Namalwa cells (Fig. 2BC), whereas the
BCD-4 epitope completely disappeared after keratanase treatment(Fig. 3A). Although Daudi and Raji cells expressed a low level of the
BCD-4 epitope, keratanase treatment signiﬁcantly increased apop-
tosis in these cells (Fig. 3B). Thus, these ﬁndings suggest that KS
plays an essential role in apoptosis in Burkitt’s lymphoma cell
lines.
PAPST1 translocates PAPS from the cytosol into the Golgi lumen
in Namalwa cells, and then sulfate is transferred from PAPS to po-
sition 6 of GlcNAc on the KS chains by three sulfotransferases
(CHST7, CHST2, and CHST6). Sulfation of KS chains was essential
for anti-apoptotic signaling, and the level of PAPST1 expression
was correlated with the extent of apoptosis induced by X-rays. In
contrast, the level of the PAPST2 transcript was less than one-
fourth of that of PAPST1, so that PAPST2 had less inﬂuence on
the level of the BCD-4 epitope (Fig. 2C), and siRNA-mediated
repression of PAPST2 did not increase radiation-induced apoptosis
(Fig. S1). However, PAPST2 has the potential to play a similar role
to PAPST1 because overexpression of PAPST2 reduced radiation-in-
duced apoptosis (Fig. 1B).
KSPG is important for the transparency of corneal tissue; how-
ever, the functional properties of KS such as anti-apoptotic effects
in other tissues are still unknown. In this study, the expression of
PAPST1 reduced radiation-induced apoptosis in Namalwa cells by
activation of the p38 MAPK and PI-3K pathways through KS bio-
synthesis (Fig. 6). In addition, pro-apoptotic signaling molecules
increased in PAPST1-repressed cells (Fig. S2). The anti-apoptotic
role of the PI-3K/AKT pathway has been well documented, and
the p38 pathway played an important role in radioprotection
through radiation-induced G2/M arrest in some cell types [16].
Various sulfated GAG subtypes can interact with FGFs [1],
which strongly enhances radioprotection including anti-apoptotic
effects [17]. Hematopoietic cells rarely express FGF receptors,
and phosphorylation of FGF receptor tyrosine kinases was not de-
tected in Namalwa-PAPST1 cells after irradiation by an antibody-
based array (data not shown); however, FGFs might inhibit
Fig. 3. Inhibitory effects of KSPG on radiation-induced apoptosis in Burkitt’s lymphoma cell lines. Three Burkitt’s lymphoma cell lines were incubated with 100 mU/ml
keratanase for 60 min to eliminate KSPG on the cell surface. (A) The treated cells were stained with anti-KS antibody (BCD-4) and subjected to FACS. (B) Cells were irradiated
with X-rays at a dose of 10, 20, or 30 Gy after keratanase treatment. The percentage of apoptotic cells was determined by Hoechst 33258 staining. Values represent the
mean ± S.D. Similar ﬁndings were observed in three independent experiments. ⁄P < 0.05; ⁄⁄P < 0.01; ⁄⁄⁄P < 0.001.
Fig. 4. Involvement of three sulfotransferases in anti-apoptotic effects in Namalwa cells. (A) Among ﬁve sulfotransferases involved in KS synthesis, CHST2, CHST6, and CHST7
could be detected in Namalwa cells but CHST1 and CHST3 could not. (B) Two of three sulfotransferases were repressed in Namalwa cells after double siRNA transfection, and
apoptosis was evaluated 24 h after irradiation. (C) All three sulfotransferases were inhibited with the triple siRNA transfection. Relative levels of CHST7, CHST2, and CHST6
transcripts in the transfectants were determined by quantitative RT-PCR. (D) The rate of apoptotic cells was determined in triple sulfotransferase-repressed cells 24 h after
irradiation. Values represent the mean ± S.D. Similar ﬁndings were observed in three independent experiments. ⁄P < 0.05; ⁄⁄P < 0.01.
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Fig. 5. Involvement of p38 MAPK in the anti-apoptotic effects of PAPST1 in
Namalwa cells. (A) Expression proﬁling of nine MAPKs and nine other serine/
threonine kinases was examined in each Namalwa transfectant using a Human
Phospho-MAPK array 6 h after irradiation. (B) The relative signal intensity was
determined using Multi Gause ver 3.0. image analysis software Each point
represents mean ± S.D. (n = 2). (C) Phosphorylation of p38 MAPK in each transfec-
tant was analyzed by western blot analysis. (D) Namalwa cells were cultured in
complete medium with an inhibitor of phosphatidylinositol-3 kinase (PI-3K), MEK,
or p38 MAPK (10 lM LY294002, 50 lM PD98059, or 50 lM SB203580) (Calbio-
chem, La Jolla, CA, USA) for 1 h and then irradiated with X-rays at 20 Gy. The
percentage of apoptotic cells was determined by Hoechst staining at 24 h after
irradiation. Values are the mean ± S.D. Similar ﬁndings were observed in two
independent experiments.
Fig. 6. Scheme of the interaction of KS biosynthesis with radiation-induced
apoptosis in Namalwa cells. PAPST1 supplies PAPS in the Golgi lumen. Sulfate is
transferred to position 6 of GlcNAc residues in KS by all three GlcNAc6STs, resulting
in the reduction of radiation-induced apoptosis through activation of p38 MAPK
and Akt.
236 F. Nakayama et al. / FEBS Letters 587 (2013) 231–237radiation-induced apoptosis without any involvement of FGF
receptors because FGF12 can be internalized into cells to play a
role in physical events [18]. Therefore, unknown extrinsic factors
might be involved in the activation of the p38 MAPK and PI-3K sig-
naling pathways through the mediation of KS, resulting in activa-
tion of an anti-apoptotic pathway in Namalwa cells (Fig. 6).
Burkitt’s lymphoma is a highly aggressive B-cell non-Hodgkin
lymphoma [19]. Intensive chemotherapy is the standard therapy
of Burkitt’s lymphoma, whereas radiation therapy is not a compo-
nent of treatment because it is not effective for the local control of
Burkitt’s lymphoma [20]. Outcomes with intensive chemotherapy
are now excellent in children owing to good supportive care, but
prognosis is still poor in elderly adults [19]. Therefore, a reduction
in the toxic effects of treatment is needed in order to improve out-
comes and the speciﬁc enhancement of radiosensitivity of Burkitt’s
lymphoma is useful for developing treatments.This study concluded that the sulfation of KSPG reduced radia-
tion-induced apoptosis in human Burkitt’s lymphoma cells. Thus,
this study provides the ﬁrst evidence that sulfated carbohydrate
chains can be a potential target for radiotherapy of Burkitt’s
lymphoma.
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